Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Thakkar Roopal. Insider active across 1 company, notably AbbVie Inc.. Cumulatively, 13 filings have been published. History available since 15 February 2024. The latest transaction was filed on 27 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Thakkar Roopal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5,792 shares0Common Stock, $0.01 par valueSEC:0001415889-24-004421:3
13 of 13 declarations
About Thakkar Roopal
Thakkar Roopal is a declarant linked to AbbVie Inc., where the company lists the role as EVP, R&D and CSO. The declarant has 13 filings in total, and the 13 sampled filings run from 2024-02-20 to 2026-03-03, with Attribution transactions and buy and sell amounts of 0 in this sample.